Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06665204 · ClinicalTrials.gov registry record · NA

Evaluating the Effectiveness of Clinical Practice Guideline Adherence for Patellofemoral Pain

A NA study of Patellofemoral Pain, sponsored by Sara Gorczynski.

Recruiting
Registry status
NA
Development phase
440
Enrollment target
1
Study location

NCT06665204: Recruiting NA study of Patellofemoral Pain, sponsored by Sara Gorczynski.

NCT06665204 is a NA study of Patellofemoral Pain that is actively recruiting participants, run by Sara Gorczynski. The registered enrollment target is 440 participants, above the 82-participant average among 5 other Patellofemoral Pain trials with a reported enrollment target (437% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06665204, a NA study of Patellofemoral Pain, is actively recruiting participants, sponsored by Sara Gorczynski.

RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this multisite, randomized clinical trial is to evaluate the short- and long-term effectiveness of a Clinical Practice Guideline (CPG)-adherent physical therapy approach to patellofemoral pain (PFP) management among military Service members. The main questions it aims to answer are: 1. Can a CPG-adherent care approach to PFP management improve short- and long-term knee function, pain, and confidence with completing duty-related activities? 2. Can a CPG-adherent care approach to PFP management reduce utilization of healthcare resources and analgesic medication prescription at 12-month follow-up? 3. Are there patient- and care-specific factors that predict or mediate clinical benefit from physical therapy care for PFP? Researchers will compare the CPG-adherent physical therapy intervention to usual physical therapy care in the Military Health System. Participants will: 1) be randomized to receive CPG-adherent care or usual care for PFP management; 2) attend physical therapy corresponding to their group assignment; and 3) complete patient-reported outcome measures at baseline and 6-weeks and 3-, 6-, and 12-months post-randomization.

Primary Outcome

The AKPS is a CPG-recommended, 13-item questionnaire assessing knee function in people with PFP, with items differentially weighted for a maximum score of 100 and higher scores indicating better function.

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Clinical Practice Guideline-adherent Care

Study Locations (1)

California

  • Naval Medical Center San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2025-08-22
Est. Completion 2028-09-29
Phase NA
Sara Gorczynski

2 total trials

What NCT06665204 shows while recruiting

NCT06665204 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 5 other Patellofemoral Pain trials with a reported enrollment target (437% higher).

The record links to 1 condition, with Patellofemoral Pain appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT06665204 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06665204 about?

NCT06665204 is a clinical study titled "Evaluating the Effectiveness of Clinical Practice Guideline Adherence for Patellofemoral Pain". The overall goal of this multisite, randomized clinical trial is to evaluate the short- and long-term effectiveness of a Clinical Practice Guideline (CPG)-adherent physical therapy approach to patellofemoral pain (PFP) management among military Service members. The main questions it aims to answer a...

What is the current status of trial NCT06665204?

This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2025-08-22. Estimated completion is 2028-09-29.

What conditions does trial NCT06665204 study?

This clinical trial studies the following conditions: Patellofemoral Pain.

What interventions are being tested in trial NCT06665204?

The interventions under investigation include: Usual Care (OTHER), Clinical Practice Guideline-adherent Care (OTHER).

Who is sponsoring clinical trial NCT06665204?

This trial is sponsored by Sara Gorczynski, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06665204 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

  • NCT05117619 · 440 participants · NA

    The HOME Program for Individuals With Traumatic Brain Injury and Family Members

  • NCT05602194 · 440 participants · Phase 3

    Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

  • NCT05624879 · 440 participants · NA

    Accelerated Resolution Therapy for Early Maladaptive Grief

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06665204, the US trial registry maintained by the National Library of Medicine. NCT06665204 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.